SingbartlG.. Adverse events of erythropoietin in long-term and in acute/short-term treatment.Clin Invest1994; 72(6S): 36–43.
2.
MarkhamA., BrysonH.M.. Epoietin alfa. A review of its pharmacodynamic use in nonrenal applications.Drugs1995; 49(2): 232–54.
3.
MercurialiF.. Eritropoietina ad autotrasfusione. In: Wichtig ed. Fisiopatologia e terapia dell'anemia.Milano: 1993; 65–71.
4.
MercurialiF., GualtieriG., SinigagliaL.. Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery.Transfusion1994; 34, 501–6.
AndoY., KaiS., UyamaE.. et al. Involvement of the central nervous system in rheumatoid arhtritis: its clinical manifestations and analysis by magnetic resonance imaging.Intern Med1995; 34(3): 188–91.
8.
ToussirrotE., SerratriceG., ValentinP.. Autonomic nervous system involvement in rheumatoid arthritis. 50 cases.J Rheumatol1993; 20(9): 1508–14.